“Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis and Skin of Color”. SKIN The Journal of Cutaneous Medicine 9, no. 2 (March 17, 2025): s549. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/3297.